- Home
- AURA vs GPAT Comparison
AURA vs GPAT Comparison
Compare AURA & GPAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURA
- GPAT
- Stock Information
- Founded
- AURA 2007
- GPAT 2020
- Country
- AURA United States
- GPAT United States
- Employees
- AURA N/A
- GPAT N/A
- Industry
- AURA Biotechnology: Pharmaceutical Preparations
- GPAT
- Sector
- AURA Health Care
- GPAT
- Exchange
- AURA Nasdaq
- GPAT NYSE
- Market Cap
- AURA 379.6M
- GPAT 365.5M
- IPO Year
- AURA 2021
- GPAT 2024
- Fundamental
- Price
- AURA $7.77
- GPAT $10.17
- Analyst Decision
- AURA Strong Buy
- GPAT
- Analyst Count
- AURA 4
- GPAT 0
- Target Price
- AURA $23.00
- GPAT N/A
- AVG Volume (30 Days)
- AURA 162.1K
- GPAT 25.9K
- Earning Date
- AURA 11-12-2024
- GPAT 01-01-0001
- Dividend Yield
- AURA N/A
- GPAT N/A
- EPS Growth
- AURA N/A
- GPAT N/A
- EPS
- AURA N/A
- GPAT 0.30
- Revenue
- AURA N/A
- GPAT N/A
- Revenue This Year
- AURA N/A
- GPAT N/A
- Revenue Next Year
- AURA N/A
- GPAT N/A
- P/E Ratio
- AURA N/A
- GPAT $33.63
- Revenue Growth
- AURA N/A
- GPAT N/A
- 52 Week Low
- AURA $6.63
- GPAT $9.98
- 52 Week High
- AURA $12.38
- GPAT $10.18
- Technical
- Relative Strength Index (RSI)
- AURA 39.85
- GPAT N/A
- Support Level
- AURA $7.46
- GPAT N/A
- Resistance Level
- AURA $7.90
- GPAT N/A
- Average True Range (ATR)
- AURA 0.30
- GPAT 0.00
- MACD
- AURA -0.00
- GPAT 0.00
- Stochastic Oscillator
- AURA 34.65
- GPAT 0.00
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.